Cargando…
Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict’s value
The purpose of the study was to test the efficacy of neoadjuvant palbociclib therapy and to evaluate its impact on cell cycle arrest and changes in EndoPredict (EP) scores before and after treatment. Postmenopausal women with histologically proven ER+ve, HER2−ve invasive breast cancer, 2 cm or great...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763422/ https://www.ncbi.nlm.nih.gov/pubmed/29158285 http://dx.doi.org/10.1530/ERC-17-0396 |